Science Current Events | Science News | Brightsurf.com
 

Molecular subtypes and genetic alterations may determine response to lung cancer therapy

May 14, 2012
Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient's individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient's response to therapy.

A UNC-led team of scientists has shown for the first time that lung cancer molecular subtypes correlate with distinct genetic alterations and with patient response to therapy. These findings in pre-clinical models and patient tumor samples build on their previous report of three molecular subtypes of non-small cell lung cancer and refines their molecular analysis of tumors.

Their findings were published in the May 10, 2012 online edition of the Public Library of Science One.

Study senior author, Neil Hayes, MD, MPH, associate professor of medicine, says, "It has been known for about a decade of using gene expression arrays that "molecular subtypes" exist. These subtypes have molecular "fingerprints" and frequently have different clinical outcomes. However, the underlying etiologies of the subtypes have not been recognized. Why do tumors form subtypes?

"Our study shows that tumor subtypes have different underlying alterations of DNA as part of the difference. These differences are further evidence of the importance of subtypes and the way we will use them. For example, the mutations are different which may imply much more ability to target than previously recognized. Also, we are starting to get a suggestion that these subtypes may reflect different cells of origin that rely on different cancer pathways. This is further unlocking the diversity of this complex disease." Hayes is a member of UNC Lineberger Comprehensive Cancer Center.

The team first defined and reported in 2006 on three lung cancer molecular subtypes, named according to their genetic pattern - bronchoid, squamoid and magnoid.

In this PLoS One paper they sought to determine if distinct genetic mutations co-occur with each specific molecular subtypes. They found that specific genetic mutations were associated with each subtype and that these mutations may have independent predictive value for therapeutic response.


University of North Carolina School of Medicine


Related Molecular Subtypes Current Events and Molecular Subtypes News Articles


Whose numbers determine cost-effectiveness of targeted anti-cancer therapies?
Health economics helps insurers, health care systems and providers make treatment decisions based on the cost of extra "units" of health arising from a specific treatment.

Thyroid cancer genome analysis finds markers of aggressive tumors
A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.

TCGA study improves understanding of genetic drivers of thyroid cancer
A comprehensive analysis of the genomes of nearly 500 papillary thyroid carcinomas (PTC) - the most common form of thyroid cancer - has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive disease development.

Researchers find why depression and aging linked to increased disease risk
Psychological stress and stress-related psychiatric disorders are associated with increased risk for aging-related diseases, but the molecular mechanisms underlying this relation are unknown.

Mayo Clinic: Ovarian cancer subtypes may predict response to bevacizumab
Molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found.

EORTC Breast cancer trial shows pathological complete response is independent predictor of favorable clinical outcome
Results of EORTC trial 10994 appearing in the Annals of Oncology show that pathological complete response after neoadjuvant chemotherapy is an independent predictive factor of favorable clinical outcomes in all molecular subtypes of breast cancer.

VHIO genomic study identifies subgroups of HER2+ breast cancer with varying sensitivities
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.

Children's National Researcher Authors Study on Pediatric Brain Stem Tumors
Children's National researcher, Javad Nazarian, PhD, authored a new study entitled, "Comparative Multidimensional Molecular Analyses of Pediatric Diffuse Intrinsic Pontine Glioma Reveals Distinct Molecular Subtypes."

Study: Metformin for Breast Cancer Less Effective at Higher Glucose Concentrations
A University of Colorado Cancer Center study published online this month in the journal Cell Cycle shows that breast cancer cell growth, motility and aggression is promoted by excess glucose, as experienced by patients with diabetes and metabolic syndrome.

The Cancer Genome Atlas exposes more secrets of lethal brain tumor
When The Cancer Genome Atlas launched its massively collaborative approach to organ-by-organ genomic analysis of cancers, the brain had both the benefit, and the challenge, of going first.
More Molecular Subtypes Current Events and Molecular Subtypes News Articles

Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics

Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics
by Lauren Pecorino (Author)


Cells in our body undergo tightly regulated replication to enable growth to occur in a precise, and to ensure that damaged or worn out tissues are replaced. Regulation is mediated via many different mechanisms; it is when these mechanisms fail, and regulation is lost, that cancer can result. Recent advances in molecular cell biology have greatly expanded our understanding of the processes and mechanisms that underpin the regulation of cell replication, and what is happening at the molecular level when these fail.

The third edition of The Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics offers a fresh approach to the study of the molecular basis of cancer, by showing how our understanding of the defective mechanisms that drive cancer is leading to the development...

Molecular Testing in Cancer

Molecular Testing in Cancer
by George M. Yousef (Editor), Serge Jothy (Editor)


Molecular Testing in Cancer provides a state of the art review of clinically relevant molecular pathology in cancer. The book provides a brief, easy to read review of commonly employed diagnostic molecular techniques including recently developed "next generation" analytic tools, and offers a system-based run-through of the utility of molecular testing in individual cancer types, as well as reviewing current markers in cancer diagnosis, prognosis, and management. The volume also provides a prospective for the future which includes recently characterized and emerging biomarkers.Written by experts in the field, Molecular Testing in Cancer serves as a useful and comprehensive resource for pathologists, hematologists, laboratory technicians and molecular scientists.

Molecular Diagnostics and Treatment of Pancreatic Cancer: Systems and Network Biology Approaches

Molecular Diagnostics and Treatment of Pancreatic Cancer: Systems and Network Biology Approaches
by Asfar Azmi (Author)


Molecular Diagnostics and Treatment of Pancreatic Cancer describes the different emerging applications of systems biology and how it is shaping modern pancreatic cancer research. This book begins by introducing the current state of the art knowledge, trends in diagnostics, progress in disease model systems as well as new treatment and palliative care strategies in pancreatic cancer. Specific sections are dedicated to enlighten the readers to newer discoveries that have emerged from gene expression profiling, proteomics, metabolomics and systems level analyses of pancreatic cancer datasets. First of a kind and novel network strategies to understand oncogenic Kras signaling in pancreatic tumors are presented. The attempts to computationally model and prioritize microRNAs that cause...

Molecular Diagnostics: 12 Tests That Changed Everything (Molecular and Translational Medicine)

Molecular Diagnostics: 12 Tests That Changed Everything (Molecular and Translational Medicine)
by W. Edward Highsmith Jr. (Editor)


Molecular Diagnostics: 12 Tests That Changed Everything focuses on specific laboratory tests and emphasizes how the availability of these tests has altered how clinicians treat their patients.  Presented as a standard outline, each chapter focuses on a specific molecular test  and provides background on the test and its clinical applications. Continuing with some discussion on how the test is done, interpreted, and used clinically, each chapter then concludes with a discussion of how that test has changed the way medicine is practiced with respect to the disease or condition in question.Authored by renowned experts in the field, Molecular Diagnostics: 12 Tests That Changed Everything is a valuable resource for pathologists, pathology residents, laboratory directors, development...

Diagnostic Molecular Pathology in Practice: A Case-Based Approach

Diagnostic Molecular Pathology in Practice: A Case-Based Approach
by Iris Schrijver (Editor)


This entirely case-based book covers a broad cross-section of the practical issues frequently encountered in the day-to-day activities of a molecular genetic pathologist. The book is divided into four sections on the principal areas addressed in molecular genetic pathology (MGP): inherited diseases, hematopathology, solid tumors, and infectious diseases. The topics covered by the cases in each section include test selection, qualitative and quantitative laboratory techniques, test interpretation, prognostic and therapeutic considerations, ethical considerations, technical troubleshooting, and result reporting.  This book will be ideal for trainees in MGP and clinical molecular genetics who require a practice-based preparation for board examinations. It will also be very useful for...

Molecular Genetics and Personalized Medicine (Molecular and Translational Medicine)

Molecular Genetics and Personalized Medicine (Molecular and Translational Medicine)
by D. Hunter Best (Editor), Jeffrey J. Swensen (Editor)


Genetic testing has become commonplace, and clinicians are frequently able to use knowledge of an individual’s specific genetic differences to guide their course of action. Molecular Genetics and Personalized Medicine highlights developments that have been made in the field of molecular genetics and how they have been applied clinically.  It will serve as a useful reference for physicians hoping to better understand the role of molecular medicine in clinical practice. In addition, it should also prove to be an invaluable resource for the basic scientist that wants to better understand how advances in the laboratory are being moved from the bench to the bedside.  All chapters are written by experts in their fields and include the most up to date medical information. The authors...

Molecular Hematology

Molecular Hematology
by Drew Provan (Editor), John Gribben (Editor)


Now in its third edition, Molecular Hematology has beenthoroughly updated to incorporate recent advances in molecularresearch. The aim of the book remains the same to provide acore knowledge base for those with little exposure to molecularbiological techniques. Molecular biology has had a significant impact on theunderstanding of blood diseases and this book shows how moleculartechniques can be used in diagnosis and treatment. In each chapterthe authors summarize the impact made by molecular research on theunderstanding of the pathogenesis of the disorder featured, andhighlight the molecular strategies that exist, or are beingcurrently investigated, for therapeutic purposes. There are sixbrand new chapters in this edition: * History and development of molecular biology *...

Molecular Pathology in Drug Discovery and Development

Molecular Pathology in Drug Discovery and Development
by J. Suso Platero (Editor)


The pharmaceutical industry is looking for new ways to better identify populations that will react positively to new drugs, and molecular pathology can fill that need. Molecular Pathology in Drug Discovery and Development provides an authoritative overview of molecular pathology and its applications and explains the significance of molecular pathology approaches to drug discovery and development. This book is an essential resource for practitioners in drug discovery and development, preclinical and clinical researchers, toxicologists and pharmacologists, molecular and cell biologists, and pathologists.

Molecular Pathology of Nervous System Tumors: Biological Stratification and Targeted Therapies (Molecular Pathology Library)

Molecular Pathology of Nervous System Tumors: Biological Stratification and Targeted Therapies (Molecular Pathology Library)
by Matthias A. Karajannis (Editor), David Zagzag (Editor)


This book serves as a comprehensive guide to the rapidly evolving field of molecular neuropathology of nervous system tumors, as well as the underlying biology and emerging molecular targeted therapies. Special emphasis is given to already established and emerging molecular diagnostic tests in neuropathology, as well as molecular targeted therapies. The book is organized by clinico-pathologic disease entities, and each chapter is written by a team of experts in their field. Molecular Pathology of Nervous System Tumors is of great value and utility for physicians and scientists involved with or interested in the up-to-date diagnosis and treatment of patients with brain tumors.

Molecular Biology of the Neuron (Molecular and Cellular Neurobiology Series)

Molecular Biology of the Neuron (Molecular and Cellular Neurobiology Series)
by F.R. Davies (Editor), Brian J. Morris (Editor)


Nerve cells - neurons - are arguably the most complex of all cells. From the action of these cells comes movement, thought and consciousness. It is a challenging task to understand what molecules direct the various diverse aspects of their function. This has produced an ever-increasing amount of molecular information about neurons, and only in Molecular Biology of the Neuron can a large part of this information be found in one source. In this book, a non-specialist can learn about the molecules that control information flow in the brain or the progress of brain disease in an approachable format, while the expert has acess to a wealth of detailed information from a wide range of topics impacting on his or her field of endeavour. In the six years since the first edition of Molecular Biology...

© 2015 BrightSurf.com